Open AccessMolecular Basis for Erythromycin Resistance in Group A Streptococcus Isolated From Skin and Soft Tissue Infections
Author(s) -
Sunil Shivekar,
Thangam Me
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/14744.6843
Subject(s) - erythromycin , penicillin , microbiology and biotechnology , biology , phenotype , streptococcus , antibiotics , streptococcus pneumoniae , genotype , antibiotic resistance , streptococcus pyogenes , bacteria , gene , genetics , staphylococcus aureus
In recent years there has been an increase in the use of erythromycin in the treatment of infections caused by bacteria other than Group A Streptococcus (GAS), which has resulted in increased resistance to this antibiotic. Erythromycin and other macrolides are alternative agents for treating GAS infections in patients, who are allergic to penicillin and its derivatives.